Financials in USD. Standardized financial statements.
A compact view of how NovoCure Limited turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $655.35M | $605.22M | $509.34M | $537.84M | $535.03M | $494.37M | $351.32M | $248.07M | $177.03M | $82.89M |
| Revenue Growth? | +8.3% | +18.8% | -5.3% | +0.5% | +8.2% | +40.7% | +41.6% | +40.1% | +113.6% | 0.0% |
| Cost of Revenue? | $166.88M | $137.18M | $128.28M | $114.87M | $114.88M | $106.50M | $88.61M | $80.05M | $55.61M | $46.28M |
| Gross Profit? | $488.47M | $468.04M | $381.06M | $422.97M | $420.15M | $387.87M | $262.71M | $168.02M | $121.42M | $36.61M |
| Gross Margin? | +74.5% | +77.3% | +74.8% | +78.6% | +78.5% | +78.5% | +74.8% | +67.7% | +68.6% | +44.2% |
| Operating Expenses? | $642.27M | $638.53M | $614.67M | $512.50M | $464.49M | $357.46M | $263.63M | $201.69M | $160.75M | $151.92M |
| Operating Income? | -$153.80M | -$170.50M | -$232.87M | -$89.52M | -$44.33M | $30.40M | -$914,000 | -$33.67M | -$39.33M | -$115.32M |
| EBITDA? | -$119.05M | -$109.58M | -$177.45M | -$67.89M | -$38.38M | $44.83M | $13.44M | -$23.45M | -$29.13M | -$108.89M |
| Income Before Tax | -$136.25M | -$131.16M | -$191.74M | -$81.85M | -$52.08M | $18.10M | -$8.82M | -$45.94M | -$48.50M | -$121.46M |
| Income Tax Expense | -$23,000 | $37.47M | $15.30M | $10.69M | $6.28M | -$1.71M | -$1.59M | $17.62M | $13.16M | $10.38M |
| Net Income? | -$136.23M | -$168.63M | -$207.04M | -$92.53M | -$58.35M | $19.81M | -$7.23M | -$63.56M | -$61.66M | -$131.84M |
| EPS? | $-1.22 | $-1.56 | $-1.95 | $-0.88 | $-0.56 | $0.20 | $-0.07 | $-0.69 | $-0.70 | $-1.54 |
| Diluted EPS? | $-1.22 | $-1.56 | $-1.95 | $-0.88 | $-0.56 | $0.18 | $-0.07 | $-0.69 | $-0.70 | $-1.54 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality